Polypharmacy and Anticholinergic Burden in Hospitalised Older Patients - A Cross Sectional Audit
|
|
- Robyn Wilcox
- 5 years ago
- Views:
Transcription
1 INTERNATIONAL JOURNAL of BIOMEDICAL SCIENCE ORIGINAL ARTICLE Polypharmacy and Anticholinergic Burden in Hospitalised Older Patients - A Cross Sectional Audit Joanna Ulley 1, Sakila Sickander 2, Ahmed H. Abdelhafiz 2 1 Department of Elderly Medicine, Rotherham General Hospital, Moorgate road, Rotherham S60 2UD, UK; 2 Department of Old Age Psychiatry, Rotherham Doncaster and South Humber NHS Foundation Trust, Woodfield House, Tickhill Road Site, Weston Rd, Doncaster DN4 8QN, UK ABSTRACT Objectives: To investigate the impact of hospital admission on polypharmacy and anticholinergic burden and explore doctors awareness of cognitive side effects of anticholinergics use. Methods: A cross sectional retrospective audit of older patients admitted to a care of elderly ward over three months. We have collected patients demographic data, number of medications and anticholinergic burden scale on admission compared to on discharge and investigated doctors knowledge about polypharmacy by answering a questionnaire. Results: 100 patients were included. Mean number of medications and anticholinergic burden were significantly higher on discharge compared to admission (9.43 v.8.27, p<0.001 and 1.50 v. 1.30, p<0.01, re4spectively). Seven doctors (25%) had no knowledge of any anticholinergic medications at all. Only 16 (57%) doctors were aware of the negative impact of this class of medications on cognitive function and 22 (79%) doctors felt not at all confident in identifying or reducing anticholinergic prescriptions for inpatients. Conclusion: Hospitalisation results in a significant increase in polypharmacy and anticholinergic burden in older people and doctors knowledge of the cognitive risks associated with anticholinergic medications in older people is poor. (Int J Biomed Sci 2018; 14 (1): 36-40) Keywords: Older people; polypharmacy; anticholinergic burden INTRODUCTION Corresponding author: Dr. Joanna Ulley, Specialty Registrar in Geriatric and Stroke Medicine, Department of Elderly Medicine, Rotherham General Hospital, Moorgate road, Rotherham, S60 2UD, UK. Joanna.ulley@nhs.net. Received August 30, 2018; Accepted September 10, 2018 Copyright: 2018 Joanna Ulley et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License ( which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. The UK population is ageing. In 2016, there was an estimated 285 older people (>65 years) for every 1000 younger people (16-64 years) and this ratio is projected to increase (1). Ageing is associated with multiple comorbidities that lead to polypharmacy and the use of inappropriate medications (2). Polypharmacy is associated with increased risk of falls, delirium, hospital admissions and increased mortality (3). One specific group of medications commonly used in older people is the anticholinergics. In the UK in 2010, an estimated 24% of older people were taking at least one drug in this class (4). This class of medications is associated with peripheral side effects such as dry mouth, urinary retention and palpitations and central 36
2 side effects such as delirium and cognitive decline. Older people are particularly susceptible to the side effects of these medications due to the high prevalence of polypharmacy in old age and the age-related changes in pharmacokinetics and pharmacodymamics (5). AIM To investigate whether hospital admission results in a reduction in polypharmacy particularly the use of anticholinergics and explores whether hospital doctors are aware of the potentially negative impact of anticholinergics use. METHODS Design A cross-sectional retrospective data analysis. Setting Acute care of the elderly ward (28 beds) which admits older patients ( 75 years) in a District General Hospital in the United Kingdom. Study sample The population comprised all elderly patients admitted to the acute medical ward over a three months period (March-June 2017) regardless of the admission diagnosis. Data collection a. Electronic Patient Records (EPR) was used to extract demographic data for each patient including age, gender and number of co-morbidities. b. The total regular medications and the number of anticholinergic medications on discharge were compared to those on admission for each patient. We calculated the anticholinergic burden (ACB) using the scale developed by the Ageing Brain Centre (6) and compared the ACB on discharge with that on admission. c. The indications for any anticholinergic medications added on discharge were extracted from the medical record for each patient. This was compared with the STOPP/ START criteria to check the appropriateness of each prescription (7). d. Doctors views regarding the prescription of anticholinergic medications in old age were explored using the following 5 questions: 1. Can you identify any anticholinergics side effects listed in this table? (Table 4) 2. Can you list as many anticholinergic medications that you know? 3. Older patients ( 75y old) are more susceptible to anticholinergic side effects, true or false? 4. Are you aware of any ACB scale? 5. How confident do you feel in identifying and reducing the ACB for susceptible patients and what are the reasons for your answer? Outcome measured a. The impact of hospital admission on polypharmacy and the ACB. b. The doctors knowledge and confidence in reducing ACB in older people. Statistical analysis Continuous data are presented as means and standard deviations (SD) and categorical data as frequencies and percentages. We used paired t-test for data comparison. The statistical software package Stata version 14, Stata- Corp, Texas, USA was used for the analysis. RESULTS During the study period, 100 patients were discharged and their baseline characteristics are summarised in Table 1. Almost half (48%) of patients had dementia diagnosis Table 1. Baseline Characteristics Total number of patients 100 Mean (SD) age, years 82.7 (8.33) Gender, female (%) 71% Mean (SD) number of co-morbidities 4.52 (2.01) Main co-morbidities (prevalence) Cardiovascular disease 58% Hypertension 53% Dementia 48% Respiratory disease 28% Depression 28% Diabetes mellitus 15% Mean (SD) length of hospital stay (days) 14.8 (14.1) Reason for admission: Falls 27% Delirium 19% Short of breath 12% Other 42% Int J Biomed Sci Vol. 14 No. 1 September
3 on admission. Delirium or fall was the presenting complaint in 46% of patients. The mean number of medications was significantly higher on discharge compared with admission (9.43 v.8.27, p<0.001). Similarly the mean ACB was significantly higher on discharge (1.50 v. 1.30, p<0.01, Table 2). Fifty-three patients had an increase in ACB during the course of their admission. Of these, thirty-one patients had a justifiable indication for an additional anticholinergic use in line with the STOPP/START criteria (7). The remaining 22 patients could have avoided the increase by either withdrawal of or the use of an alternative treatment. (Table 3) Doctors views regarding the reasons for the ACB stasis or increase during admission are summarised in Table 4. A total of 28 doctors (4 senior doctors, 5 middle grades, and 19 junior doctors) answered a questionnaire regarding the use of anticholinergic medications in older people. Seven doctors (25%) had no knowledge of any anticholinergic medications at all. Of those that could, oxybutynin was the most commonly cited example of this category. All doctors knew that older people are more susceptible to the peripheral nervous system side effects of anticholinergics. However, only 57% of doctors were aware of the negative impact of this class of medications on cognitive function. Twenty two (79%) doctors felt not at all confident in identifying or reducing anticholinergic prescriptions for inpatients. The most commonly cited reason for this was Lack of awareness of anticholinergic risk. DISCUSSION This study demonstrated that a hospital admission resulted in an increase, rather than a decrease in the overall medication burden. This is likely to be due to the fact that patients are admitted with an additional illness which may require further medications. It has been previously reported that average number of all medications has significantly increased from 2.89 on hospital admission to 3.75, p< on discharge (8). Other studies showed similar results (9, 11). In our study, a significant proportion (46%) of acute presentations to hospital was due to either a fall or altered mental state. A study of community-dwelling older people exploring the link between exposure to anticholinergic or sedative medications and performance on physical and cognitive functioning demonstrated a clear Table 3. Anticholinergic medications inappropriately used in 22 patients according to STOPP/START criteria (7) Medication group Incontinence medications Number of patients Fesoterodine 2 Solifenacin 1 Trospium 1 Tolterodine 1 Oxybutynin 1 Tricyclic Antidepressant Amitriptyline 4 Beta-Blockers Atenolol 3 Vitamin K antagonists Warfarin 2 Analgesia Codeine 1 Nefopam 1 Carbamazapine 1 Antihistamine Other Hydroxyzine 1 Chlorpromazine 1 Loperamide 1 Furosemide 1 Total 22 Table 2. Comparison between admission and discharge medications per patient Admission Discharge Difference (95% CI) Mean (SD) total number of medications 8.27(4.80) 9.43(5.10) 1.26 (1.63 to 2.37), p<0.001 Mean (SD) ACB 1.30 (1.6) 1.50 (1.62) 0.2 (0.05 to 0.3), p=0.010 CI, Confidence interval; ACB, Anticholinergic burden. 38
4 Table 4. Doctors awareness of anticholinergic burden survey (28 doctors) Can you list as many anticholinergic medications that you know? Can you identify any anticholinergics side effects? (doctors were shown 9 side effects) Awareness of nervous system side effects Peripheral symptoms Central symptoms (delirium) Are you aware of any ACB scale? How confident do you feel in identifying and reducing the ACB for susceptible patients? Reason for lack of confidence : 21 (75%) doctors had knowledge of anticholinergics. 7 (25%) doctors had no knowledge of any anticholinergics. 15 doctors (54%) identified 6/9 side effects. 13 doctors (46%) identified <6/9 side effects. 28 (100%) doctors. 16 (57%) doctors Lack of awareness of ACB. 14 (64%)* Lack of knowledge of which drugs are anticholinergics. 6 (27%) Risk of patient losing benefit of anticholinergic medication. 6 (27%) Unwilling to alter a colleague s prescription. 2 (9%) *Some doctors gave more than one answer. 19 (68%) doctors not aware. 9 (32%) doctors aware. 22 (79%) doctors are not confident. 6 (21%) doctors are confident. association between dose burden and functional decline (12). This has led to the emergence of the concept of drug burden index that quantifies the dose and the frequency of these high risk medications and provides a useful evidence-based tool for assessing the potential harms of these medications in older people (12). We have focused on the ACB due to the particular risk posed by these medications on older people and its association with cognitive decline. It might therefore be expected that for older patients admitted to hospital, the opportunity to rationalise or reduce the ACB would be undertaken. A larger scale study set out to identify risk factors that increase the patient s chance of being prescribed such medications found that poor mobility, urinary incontinence, depression and Parkinson s disease were among the most important risk factors that lead to anticholinergic medications use (13). A similar study examined the impact of a hospital admission on the drug burden index concluded that drug management of older patients during hospital stay may increase the exposure to such medications (14). With this in mind, we examined our data relating to the anticholinergic use specifically in order to investigate whether the changes were clinically justifiable or not. If there was a questionable use of the anticholinergic medication, in line with the STOPP/START criteria (7), the prescription was deemed avoidable or inappropriate. Using these criteria, we found that for 22 of the 53 patients taking anticholinergic drugs on admission, the indication for treatment was not clear, or an alternative medication could be found. With regards to the doctors survey, our study has demonstrated that hospital doctors have a significant lack of awareness regarding the existence of ACB tool and lack of knowledge regarding the associated cognitive decline risks in older age group. A recent study has reported lack of knowledge among different health care professionals, particularly general practitioners (15). STRENGTHS AND LIMITATIONS In this case the retrospective analysis, rather than prospective, was advantageous as doctors may reduce their anticholinergic prescribing if they were aware of data collection in a prospective design. This study also provides information about doctors views in particular junior doctors knowledge and understanding of the hazards of prescribing in this age group, an area which is less well covered in the literature. One limitation is that the questionnaires were provided for medical staff only; more information may have been gleaned from a greater number of participants i.e. nurse practitioners and pharmacists. Another is the small number of patients that was limited to one ward. Int J Biomed Sci Vol. 14 No. 1 September
5 CONCLUSION Hospitalisation of older people appears to increase polypharmacy and ACB scale. Reasons for this increase remain unclear but are likely to include failure by hospital doctors, especially the juniors, to recognise and address the risks associated with anticholinergic prescribing. Further research to investigate whether raising awareness amongst frontline medical staff would positively impact on the treatment burden in older people is warranted. KEY POINTS Hospitalisation results in a significant increase in anticholinergic burden amongst older people. Doctors awareness of the cognitive risks associated with anticholinergic medications in older people is lacking. REFERENCES 1. Overview of the UK population: July 2017 Office for National Statistics (accessed September 2018). 2. Ramhade S, Chakarborty A, Shrivastava A, et al. A Survey on Polypharmacy and Use of Inappropriate Medications. Toxicol Int. 2012; 19: Fried TR, O Leary J, Towle V, et al. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J. Am. Geriatr. Soc. 2014; 62: Sumukadas D, McMurdo ME, Mangoni AA, et al. Temporal trends in anticholinergic medication prescription in older people: repeated cross-sectional analysis of population prescribing data. Age Ageing. 2014; 43: Boustani M, Campbell N, Munger S, Maidment I, et al. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health. 2008; 4: Indiana University-Center for Aging Research-Aging Brain Program 2012 Update (accessed September 2018). 7. Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Person s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. 2008; 46: Beers MH, Dang J, Hasegawa J, et al. Influence of hospitalization on drug therapy in the elderly. J. Am. Geriatr. Soc. 1989; 37: Betteridge TM, Frampton CM, Jardine DL. Polypharmacy--we make it worse! A cross-sectional study from an acute admissions unit. Intern. Med. J. 2012; 42: Gutiérrez-Valencia M, Izquierdo M, Malafarina V, et al. Impact of hospitalization in an acute geriatric unit on polypharmacy and potentially inappropriate prescriptions: A retrospective study. Geriatr. Gerontol. Int. 2017; 17: Frankenthal D, Lerman Y, Lerman Y. The impact of hospitalization on potentially inappropriate prescribing in an acute medical geriatric division. Int. J. Clin. Pharm. 2015; 37: Hilmer SN, Mager DE, Simonsick EM, et al. A Drug Burden Index to Define the Functional Burden of Medications in Older People. Arch. Intern. Med. 2007; 167: Wawruch M, Macugova A, Kostkova L, et al. The use of medications with anticholinergic properties and risk factors for their use in hospitalised elderly patients. Pharmacoepidemiol Drug Saf. 2012; 21: Dauphinot V, Faure R, Bourguignon L, et al. Factors associated with changes in exposure to anticholinergic and sedative medications in elderly hospitalised patients: a multicentre longtidinal study. Eur. J. Neurol. 2017; 24: Araklitis G, Thiagamoorthy G, Hunter J, et al. Anticholinergic prescription: are healthcare professionals the real burden? Int. Urogynecol J. 2017; 28:
Geriatric Pharmacology
Geriatric Pharmacology Janice Scheufler R.Ph.,PharmD, FASCP Clinical Pharmacist Hospice of the Western Reserve Objectives List three risk factors for adverse drug events in the elderly Discuss two physiological
More informationKatee Kindler, PharmD, BCACP
Speaker Introduction Katee Kindler, PharmD, BCACP Current Practice: Clinical Pharmacy Specialist Ambulatory Care, St. Vincent Indianapolis Assistant Professor of Pharmacy Practice, Manchester University,
More informationManaging medicines in older people. Jane Noble and Caroline Ralph
Managing medicines in older people Jane Noble and Caroline Ralph Where? Community Hospital Care Home What? Prescribing Dispensing Administering Case 1 84 year old lady Admitted with reduced mobility Recurrent
More informationAppropriate prescribing and deprescribing for older people getting it right. Alan Davis Northland District Health Board
Appropriate prescribing and deprescribing for older people getting it right Alan Davis Northland District Health Board Unused returns Potentially inappropriate medication use in the elderly 15% of older
More informationPotentially Inappropriate Medications in Elderly Haemodialysis Patients Using the STOPP Criteria. Krystina Parker, Willy Aasebø & Knut Stavem
Potentially Inappropriate Medications in Elderly Haemodialysis Patients Using the STOPP Criteria Krystina Parker, Willy Aasebø & Knut Stavem Drugs - Real World Outcomes ISSN 2199-1154 Drugs - Real World
More informationCompleted audit cycle to explore the use of the STOPP/START toolkit to optimise medication in psychiatric in-patients with dementia
Completed audit cycle to explore the use of the STOPP/START toolkit to optimise medication in psychiatric in-patients with dementia Victor M. Aziz, Natalie Hill, Sugandha Kumar BJPsych Bulletin (08) 4,
More informationApplication for Endorsement of CQI (Clinical Audit) Activities for MOPS Credits Allocation
Application for Endorsement of CQI (Clinical Audit) Activities for MOPS Credits Allocation Below is the form you need to fill out. NAME Dianne Vicary Health Hawke s Bay DATE JUNE 2012 TITLE OF ACTIVITY
More informationA Study to Assess the Anti Cholinergic Burden Index among Geriatrics
A Study to Assess the Anti Cholinergic Burden Index among Geriatrics * Ahamada Safna Mariyam M, Surya Prabhath K, Siva Ram Prasad S, M. D. Dhana Raju GIET School of Pharmacy, Rajahmundry, East Godavari
More informationIatrogenesis in the frail elderly
Iatrogenesis in the frail elderly Professor Michael Dooley Director of Pharmacy Alfred Health Professor of Clinical Pharmacy Centre for Medicine Use and Safety Monash University Iatrogenesis in the frail
More informationUpdate in Geriatrics: Choosing Wisely Primum Non Nocere
Joseph G. Ouslander, M.D. Professor of Clinical Biomedical Science Senior Associate Dean for Geriatric Programs Chair, Department of Integrated Medical Science Charles E. Schmidt College of Medicine Professor
More informationStronger together - optimizing pharmacotherapy on geriatric wards?
Stronger together - optimizing pharmacotherapy on geriatric wards? Clinicamp FOD 27/4/2018 Dr. Jean-Claude Lemper ( Geriater UZ Brussel) Apr. Julie Hias (ziekenhuisapotheker UZ Leuven) Project College
More informationPolypharmacy and Polymorbid Patients: Practical Tips and Tricks
Polypharmacy and Polymorbid Patients: Practical Tips and Tricks November 2, 2013 Faculty/Presenter Disclosure Faculty: Chris Fan-Lun, BScPhm, ACPR, CGP Pharmacist - Geriatric Medicine Clinical Practice
More informationPRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas
PRESCRIBING IN THE ELDERLY CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas LEARNING OUTCOMES Medicines Optimisation The effects of aging on health and medicines. Polypharmacy Acute Kidney
More information< = > less is more. De-diagnosing De-prescribing Non-testing
< = > less is more De-diagnosing De-prescribing Non-testing Who says? Overdiagnosis Polypharmacy False positives Too much medicine Risk aversion $$$ Sources Prof David Le Couteur, Clin Pharm and Aged Care
More informationSupporting and Caring in Dementia
Supporting and Caring in Dementia Surrey and Sussex Healthcare, Delivering the National Dementia Strategy Strategy and Implementation Plan Final November 2011 1 National Strategy The National Dementia
More information4/26/2016 DISCLOSURES BACKGROUND OBJECTIVES BACKGROUND BACKGROUND
http://thinkprogress.org/health/01/10//1061/how-rising-health-care-costs-impact-the-national-budget/ http://www.firstaidforfree.com/wp-content/uploads/015/09/falls.jpg http://drwills.com/wp-content/uploads/015/05/drugcycle.jpg
More informationDrug use in long term care. Graziano Onder Centro Medicina Invecchiamento Università Cattolica Sacro Cuore, Rome
Drug use in long term care Graziano Onder Centro Medicina Invecchiamento Università Cattolica Sacro Cuore, Rome Polypharmacy in nursing home (USA) Concurrent use of 9 medications was reported for 39.7%
More information9 Diabetes care. Back to contents
Back to contents Diabetes is a major risk factor for the development of peripheral vascular disease and 349/628 (55.6%) of the patients in this study had diabetes. Hospital inpatients with diabetes are
More informationBriefing Document on Medication use and Falls
Briefing Document on Medication use and Falls This document is intended as a briefing document and is not to be regarded as a document offering definitive legal advice in relation to the subject matter.
More informationFrailty and polypharmacy in elderly patients are associated with a high readmission risk
Dan Med J 63/9 September 2016 danish medical JOURNAL 1 Frailty and polypharmacy in elderly patients are associated with a high readmission risk Elizabeth Rosted 1, Martin Schultz 2 & Suzanne Sanders 3
More informationSTOPP and START criteria October 2011
# START and STOPP are newer criteria to identify potentially inappropriate medications in elderly, including drug drug and drug disease interactions, drugs which increase risk of falls and drugs which
More informationDefine frailty Recognise the consequences of frailty Know why CGA important and what are the main components of a CGA that can be done in an initial
Dr Kyra Neubauer Define frailty Recognise the consequences of frailty Know why CGA important and what are the main components of a CGA that can be done in an initial assessment Understand what are potential
More informationMedication Use & Risk of Cognitive Decline
Medication Use & Risk of Cognitive Decline Malaz Boustani, MD, MPH Richard M Fairbanks Professor of Aging Research Indiana University School of Medicine 1 Disclosure No conflict of Interest. Funding provided
More informationMedication safety in vulnerable patient groups - Elderly patients -
Woodennature/CC-BY-SA-3.0 http://theintelligence.de Medication safety in vulnerable patient groups - Elderly patients - 20th Congress of EAHP 25-27 March, 2015, Hamburg, Germany Dr. rer. nat. Beate Wickop
More informationDeprescribing Unnecessary Medications: A Four-Part Process
Deprescribing Unnecessary Medications: A Four-Part Process Scott Endsley, MD Fam Pract Manag. 2018;25(3):28-32. Abstract and Introduction Introduction www.medscape.com Ms. Horatio is a 76-year-old patient
More informationPolymedication in nursing home. Graziano Onder Centro Medicina dell Invecchiamento Università Cattolica del Sacro Cuore Rome - Italy
Polymedication in nursing home Graziano Onder Centro Medicina dell Invecchiamento Università Cattolica del Sacro Cuore Rome - Italy Services and Health for Elderly in Long TERm care (SHELTER) 4156 residents
More informationDeconstructing Polypharmacy. Alan B. Douglass, M.D. Director
Deconstructing Polypharmacy Alan B. Douglass, M.D. Director Recognize this patient? Mrs. Brown- 82 years young Active Medical Problems Hypertension Hyperlipidemia Type 2 Diabetes Peripheral edema Osteoarthritis
More informationThere s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients
There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients Marilyn N. Bulloch, PharmD, BCPS Assistant Clinical Professor
More informationPrescribing Drugs to the Elderly
Answers to your questions from University of Toronto experts Prescribing Drugs to the Elderly Can drugs do more harm than good? M.A. is a 90-year-old man living at home. He has dementia and due to wandering
More informationPharmaceutical Care for Geriatrics
Continuing Professional Pharmacy Development Program Pharmaceutical Care for Geriatrics Presented by: Alla El-Awaisi; MPharm, MRPharmS, MSc Event Organizer: Dr. Nadir Kheir; PhD Disclaimer: PRESENTING
More informationConflict of interest declaration and sources of funding
Potentially Inappropriate Prescribing immediately prior to Long-Term Care admission (PIP in LTC): Validation of tools for their future use across Ontario Bruyère CLRI Webinar March 24 th, 2016 and Bruyère
More informationRational Pharmacotherapy for LUTS in Older People. Dr William Gibson MBChB MRCP
Rational Pharmacotherapy for LUTS in Older People Dr William Gibson MBChB MRCP Frailty Frailty = state of increased vulnerability resulting from agingassociated decline in reserve and function NOT synonymous
More informationTemporal trends in anticholinergic medication prescription in older people: repeated crosssectional analysis of population prescribing data
Temporal trends in anticholinergic medication prescription in older people Age and Ageing 2014; 43: 515 521 doi: 10.1093/ageing/aft199 Published electronically 10 December 2013 The Author 2013. Published
More informationAssociation between Potentially Inappropriate Prescription (PIP) and Health Outcome Among Geriatric Home Residents
The Egyptian Journal of Hospital Medicine (July 2018) Vol. 72 (6), Page 4660-4665 Association between Potentially Inappropriate Prescription (PIP) and Health Outcome Among Geriatric Home Residents Moatassem
More informationDEPRESCRIBING IN THE ELDERLY
DEPRESCRIBING IN THE ELDERLY G E R I A T R I C S R E F R E S H E R D A Y W E D N E S D A Y, A P R I L 5 TH, 2 0 1 7 V É R O N I Q U E F R E N C H M E R K L E Y, M D, C C F P ( C O E ) B R U Y È R E C O
More informationSafe Prescribing in Dementia
Safe Prescribing in Dementia Dr Daniel Harwood Consultant Psychiatrist and Clinical Director, London Strategic Clinical Network Gurdeep Kaur Major Rapid Access Team Senior Pharmacist, Camden CNWL NHS Trust
More informationTRAUMA AND THE GERIATRIC PATIENT. Janine Clift, RN Geriatric Emergency Nurse University Hospital Emergency Department, LHSC April 28, 2011
TRAUMA AND THE GERIATRIC PATIENT Janine Clift, RN Geriatric Emergency Nurse University Hospital Emergency Department, LHSC April 28, 2011 ELDERLY PATIENT ARE NOT JUST OLDER ADULTS Fraility is like pornography,
More informationThe Role of Pharmacists achieving international best practice standards and realising key opportunities.
The Role of Pharmacists achieving international best practice standards and realising key opportunities. Dr. Stephen Byrne Senior Lecturer in Clinical Pharmacy & Director of the MSc in Clinical Pharmacy
More informationPrevalence of Polypharmacy in Geriatric Patients in Rural Teaching Hospital
Original Article Prevalence of Polypharmacy in Geriatric Patients in Rural Teaching Hospital Maheshkumar V.P.* and Dhanapal C.K Department of Pharmacy, Annamalai University, Chidambaram- 608002, Tamil
More informationSTART, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy
START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy Jessica DiLeo, PharmD Kate Murphy, PharmD OBJECTIVES Identify pharmacodynamic and pharmacokinetic parameters that may influence treatment
More informationThe Clinical Frailty Scale predicts inpatient mortality in older hospitalised patients with idiopathic Parkinson s disease.
J R Coll Physicians Edinb 2018; 48: 103 7 doi: 10.4997/JRCPE.2018.201 PAPER The Clinical Frailty Scale predicts inpatient mortality in older hospitalised patients with idiopathic Parkinson s disease Clinical
More informationThe audit is managed by the Royal College of Psychiatrists in partnership with:
Background The National Audit of Dementia (NAD) care in general hospitals is commissioned by the Healthcare Quality Improvement Partnership on behalf of NHS England and the Welsh Government, as part of
More informationPolypharmacy and Deprescribing for Older People
Polypharmacy and Deprescribing for Older People Sarah Hilmer Head of Department, Clinical Pharmacology and Senior Staff Specialist Aged Care, RNSH Conjoint Professor of Geriatric Pharmacology, Sydney University
More informationPolypharmacy. in the Elderly. Lesley Charles, MBChB, CCFP
Polypharmacy in the Elderly Lesley Charles, MBChB, CCFP Associate Professor and Program Director Division of Care of the Elderly Department of Family Medicine, University of Alberta March 06, 2016 1 Faculty/Presenter
More informationAround fifteen semi-structured interviews are going to be conducted with specialist physicians of the domains selected for the checklist.
1 SEMI-STRUCTURED INTERVIEW GUIDE THE INTERVIEW PROCESS This interview is intended to create statements of potential interest for a prescription-screening checklist to detect potentially inappropriate
More informationDelirium. Geriatric Giants Lecture Series Divisions of Geriatric Medicine and Care of the Elderly University of Alberta
Delirium Geriatric Giants Lecture Series Divisions of Geriatric Medicine and Care of the Elderly University of Alberta Overview A. Delirium - the nature of the beast B. Significance of delirium C. An approach
More informationScreening tools for elderly patients in primary care
Screening tools for elderly patients in primary care Cristín Ryan 1 Prof. Julia Kennedy 1 Dr. Denis O Mahony 2 Dr. Stephen Byrne 1 Co-Investigator: Dr. Paul Gallagher 2 1 Pharmaceutical Care Research Group,
More informationDelirium in the Elderly
Delirium in the Elderly ELITE 2015 Mamata Yanamadala M.B.B.S, MS Division of Geriatrics Why should we care about delirium? It is: common associated with high mortality associated with increased morbidity
More informationGeriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center
Geriatric Pharmacology Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center Silver Tsunami 2010: 40 million (13%) 2030: 72 million (20%) Baby Boomers (1946-1964)
More informationThank You to Our Sponsors: Evaluations & CE Credits. Featured Speakers. Conflict of Interest & Disclosure Statements 10/18/2016
Thank You to Our Sponsors: University at Albany School of Public Health NYS Department of Health Conflict of Interest & Disclosure Statements The planners and presenters do not have any financial arrangements
More informationPRESCRIBING FOR PEOPLE WITH DEMENTIA; SELECTED FINDINGS FROM POMH-UK QUALITY IMPROVEMENT PROGRAMMES (QIPS)
PRESCRIBING FOR PEOPLE WITH DEMENTIA; SELECTED FINDINGS FROM POMH-UK QUALITY IMPROVEMENT PROGRAMMES (QIPS) The Prescribing Observatory for Mental Health (POMH-UK) is a national initiative to improve the
More informationPatient Safety in Older Adults
Patient Safety in Older Adults Scott Martin Vouri, PharmD, MSCI, BCPS, BCGP, FASCP St. Louis College of Pharmacy Faculty Disclosure Dr. Vouri is funded by the Washington University Institute of Clinical
More informationPharmacology in the Elderly
Pharmacology in the Elderly James Hardy Geriatrician, Royal North Shore Hospital A recent consultation Aspirin Clopidogrel Warfarin Coloxyl with senna Clearlax Methotrexate Paracetamol Pantoprazole Cholecalciferol
More informationPatient Safety in Older Adults
Patient Safety in Older Adults Scott Martin Vouri, PharmD, MSCI, BCPS, BCGP, FASCP St. Louis College of Pharmacy Faculty Disclosure Dr. Vouri is funded by the Washington University Institute of Clinical
More informationHow to prevent delirium in nursing home. Dr. Sophie ALLEPAERTS Geriatric department CHU-Liège Belgium
How to prevent delirium in nursing home Dr. Sophie ALLEPAERTS Geriatric department CHU-Liège Belgium 1 CONFLICT OF INTEREST DISCLOSURE I have no potential conflict of interest to report 2 Outline 1. Introduction
More informationThe Management of Overactive Bladder Syndrome with Antimuscarinic Drugs
The Management of Overactive Bladder Syndrome with Antimuscarinic Drugs Author Version Date Consultation Date of Ratification By JPG Shaista Hussain Joint Formulary Pharmacist V2 16.09.2014 Homerton University
More informationIdentifying and reducing medication errors in mental health
Identifying and reducing medication errors in mental health Hilary Scott Chief Pharmacist South Essex Partnership University NHS Trust with valuable input from Ian Maidment, Senior Lecturer in Clinical
More informationPolypharmacy and Elders. Leslie Baker, Pharm. D., RPh, CGP Sanford Center for Aging
Polypharmacy and Elders Leslie Baker, Pharm. D., RPh, CGP Sanford Center for Aging Prescription Medication Use In Elders 1 13% of the US population is age 65+ Age 65 years 13% Age 65+ account for 34% of
More informationCOMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK
COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK Robert L Alesiani, PharmD, CGP Chief Pharmacotherapy Officer CareKinesis, Inc. (a Tabula Rasa Healthcare Company) 2 3 4 5 Pharmacogenomics
More informationASPIRIN MISUSE AT HOME ACCORDING TO START AND STOPP IN FRAIL OLDER PERSONS
ASPIRIN MISUSE AT HOME ACCORDING TO START AND STOPP IN FRAIL OLDER PERSONS O. Dalleur 1,4, B. Boland 2,3, A. Spinewine 4-5 1 Pharmacy and 2 Geriatric Medicine, St-Luc university Hospital, 3 Institute of
More informationAbout ISMP Canada. Analysis Outputs: Safety Bulletins. Less is More: An Introduction to Deprescribing. canada.org
Less is More: An Introduction to Deprescribing Lindsay Yoo, BSc, BScPhm, RPh, CDE, CGP, PharmD Medication Safety Analyst, ISMP Canada About ISMP Canada The Institute for Safe Medication Practices Canada
More informationDelirium in the Elderly
Delirium in the Elderly ELITE 2017 Liza Genao, MD Division of Geriatrics Why should we care about delirium? It is: common associated with high mortality associated with increased morbidity Very much under-recognized
More informationPreventing Falls in Older Adults A Matter of Safety
Preventing Falls in Older Adults A Matter of Safety Roger Tam, BSc. Pharm. Wal-Mart Clinical Designated Pharmacist Falls Prevention Pharmacist Specialist NCCHC-Pre/Post Test Educator Q.U.I.T Educator Overview
More informationPrescribing Dilemmas. Sue Mulvenna Head of Pharmacy and CD Accountable Officer South Region SW 19 th May
Prescribing Dilemmas Sue Mulvenna Head of Pharmacy and CD Accountable Officer South Region SW 19 th May 2016 The four principles of medicines optimisation Aim to understand the patient s experience Evidence
More informationMedications are Additive (Anticholinergic) Diane W. Healey, M.D. Center for Healthy Aging March 10, 2017
Medications are Additive (Anticholinergic) Diane W. Healey, M.D. Center for Healthy Aging March 10, 2017 Disclosures This speaker has indicated there are no relevant financial relationships to be disclosed.
More informationPolypharmacy and the Older Adult. Leslie Baker, PharmD, BCGP Umanga Sharma, MD
Polypharmacy and the Older Adult Leslie Baker, PharmD, BCGP Umanga Sharma, MD Objectives Identify what polypharmacy is Identify factors leading to polypharmacy Discuss consequences of polypharmacy Identify
More informationCognitive Safety of Pharmacological Treatment of Urinary Incontinence: Will I make my patient worse?
Cognitive Safety of Pharmacological Treatment of Urinary Incontinence: Will I make my patient worse? Adrian Wagg, MB, FRCP, FHEA Division Director, Geriatric Medicine University of Alberta Zone Programme
More informationThe Industry s Views on Older Old Patients
The Industry s Views on Older Old Patients Susanna Del Signore and Philippe Guillet Global Regulatory Policy and Ageing Therapeutic Strategic Unit SANOFI R&D 1 Outline Introduction EFPIA Survey: Overview
More informationLegemiddelbruk og hoftebrudd
Legemiddelbruk og hoftebrudd Oppsummering av ph.d. GerIT 05.04.16 LIS Marit Stordal Bakken Haraldsplass Diakonale Sykehus U N I V E R S I T Y O F B E R G E N Potentially inappropriate drug use and hip
More informationFalls Assessment and Medication
Falls Assessment and Medication Professor T.Masud President-Elect British Geriatrics Society Nottingham University Hospitals NHS Trust, UK Visiting Professor University of Southern Denmark Mrs GH is a
More informationWelcome to the Routine frailty identification in the GP contract webinar presented by Dawn Moody
Welcome to the Routine frailty identification in the GP contract webinar presented by Dawn Moody The presentation will begin at 12.00pm. Attendees will be muted during the presentation to avoid interference.
More informationAdepu and Adusumilli: Drug-related Problems in Patients with Chronic Diseases in South India
Assessment of Drug-related Problems in Patients with Chronic Diseases through Health Status Survey in a South Indian Rural Community Setting R. ADEPU* AND P. K. ADUSUMILLI Department of Pharmacy Practice,
More informationAppendix L: Research recommendations
1 L.1 Dementia diagnosis (amyloid PET imaging) recommendation 1 Index Test Reference Test(s) Does amyloid PET imaging provide additional diagnostic value, and is it cost effective, for the diagnosis of
More informationSelecting the right patient for medication reviews
Selecting the right patient for medication reviews Prof dr Petra Denig, Clinical Pharmacy & Pharmacology, University Medical Center Groningen, the Netherlands 2 Who is in need of medication review: can
More informationTackling inappropriate polypharmacy in NHS Scotland
Tackling inappropriate polypharmacy in NHS Scotland Francesca Aaen Lead Care Homes Pharmacist - NHS Lanarkshire Heather Harrison - Senior Prescribing Advisor/ Chronic Pain Primary Care Service Development
More informationNumber of records submitted: 14,750 Number of participants: Part 1 = 146 hospitals (120 trusts); Part 2 = 140 hospitals (119 trusts)
British Thoracic Society Smoking Cessation Audit Report Smoking cessation policy and practice in NHS hospitals National Audit Period: 1 April 31 May 2016 Dr Sanjay Agrawal and Dr Zaheer Mangera Number
More informationA Systematic Approach to
A Systematic Approach to Drug Regimen Review REVISITING INTRODUCTION This article is the third in a threepart series exploring drug regimen review (DRR) over the last 30 years. In the first part, we explored
More informationAppropriateness of prescribing in older patients
Appropriateness of prescribing in older patients Which tools should be used? Anne Spinewine MPharm, MSc, PhD Université catholique de Louvain, Belgium Louvain Drug Research Institute and CHU Mont-Godinne
More informationSTOPP START Toolkit Supporting Medication Review in the Older Person
STOPP START Toolkit Supporting Medication Review in the Older Person STOPP: Screening Tool of Older People s potentially inappropriate Prescriptions START: Screening Tool to Alert doctors to Right (appropriate,
More informationEvidence-Based Clinical Practice Guideline for Deprescribing Cholinesterase Inhibitors and Memantine in People with Dementia
Evidence-Based Clinical Practice Guideline for Deprescribing Cholinesterase Inhibitors and Memantine in People with Dementia ADI 2018, Chicago FACULTY OF MEDICINE Dr Emily Reeve NHMRC Cognitive Decline
More informationPotentially Inappropriate Medications in Elderly Patients: Prevalence at Admission and Changes During Hospital Stay
Potentially Inappropriate Medications in Elderly Patients: Prevalence at Admission and Changes During Hospital Stay Background Polypharmacy in the Elderly 40% seniors are using 5-9 different classes of
More informationLet it go! Rationalising medicines for patients with life limiting illness
Let it go! Rationalising medicines for patients with life limiting illness Inga Andrew Senior Clinical Pharmacist Northumbria Healthcare Trust E-mail: inga_andrew@northumbria-healthcare.nhs.uk Welcome
More informationPolypharmacy in the Elderly
Polypharmacy in the Elderly Or How Scotland invented the Modern World Sir William Ferguson Anderson 1914-2001 Became the first Professor of Geriatrics in the world when he was appointed to the David Cargill
More informationSame day acute frailty services
Ambulatory emergency care guide Same day acute frailty services Published by NHS Improvement, NHS England, the Ambulatory Emergency Care Network and the Acute Frailty Network June 2018 Contents Introduction...
More informationObjectives. Polypharmacy Seminar. Causes of Polypharmacy. Polypharmacy 8/05/12. National Prescribing Curriculum Module
Polypharmacy Seminar Objectives On completion of this module you should be able to: state the major guiding principles in rational prescribing recognise, and substantiate, over-prescribing or inappropriate
More informationOptimising Safe & Appropriate Medicines Use and Deprescribing. Katie Smith, Director, East Anglia Medicines Information Service February 2014
Optimising Safe & Appropriate Medicines Use and Deprescribing Katie Smith, Director, East Anglia Medicines Information Service February 2014 Background Objectives How & why the OSAMU document was developed
More informationMental Health in STH Mike Richmond, Medical Director Mark Cobb, Clinical Director of Professional Services Debate & Note
SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY REPORT TO THE TRUST HEALTHCARE GOVERNANCE COMMITTEE E TO BE HELD ON 27 FEBRUARY 2012 Subject: Supporting Director: Author: Status 1 Mental
More informationUse of Anti-Psychotic Agents in Irish Long Term Care Residents with Dementia
Use of Anti-Psychotic Agents in Irish Long Term Care Residents with Dementia Aine Leen, Kieran Walsh, David O Sullivan, Denis O Mahony, Stephen Byrne, Margaret Bermingham Pharmaceutical Care Research Group,
More informationPOLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE
POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE Jeannie Kim Lee, PharmD, BCPS, CGP Clinical Pharmacy Director College of Pharmacy The University of Arizona Learning Objectives: State the risks of
More informationDeprescribing: reducing inappropriate polypharmacy
MEDICINES OPTIMISATION Deprescribing: reducing inappropriate polypharmacy ANGELA DOWDEN Inappropriate prescribing and polypharmacy, particularly in elderly patients, is associated with increased risk of
More informationSummary of funded Dementia Research Projects
Summary of funded Dementia Research Projects Health Services and Delivery Research (HS&DR) Programme: HS&DR 11/2000/05 The detection and management of pain in patients with dementia in acute care settings:
More informationNCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT
NCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT CONTENTS PATIENTS ADMITTED WITH HEART FAILURE...4 Demographics... 4 Trends in Symptoms... 4 Causes and Comorbidities
More informationGeriatrics and Cancer Care
Geriatrics and Cancer Care Roger Wong, BMSc, MD, FRCPC, FACP Postgraduate Dean of Medical Education Clinical Professor, Division of Geriatric Medicine UBC Faculty of Medicine Disclosure No competing interests
More informationQuality of Acute Care for Older Persons with Dementia
Quality of Acute Care for Older Persons with Dementia A Hospital-Based Pilot Study Chien-Liang Liu Center for Geriatrics and Gerontology, Taipei Veterans General Hospital, Taiwan 2013/04/20 Outline Background
More informationThe Geriatrician in the Trauma Service. Trauma Quality Improvement Program (TQIP) Annual Scientific Meeting and Training 2013
The Geriatrician in the Trauma Service Trauma Quality Improvement Program (TQIP) Annual Scientific Meeting and Training 2013 Challenges of the Geriatric Trauma Patient Challenges of the Geriatric Patient
More informationUse of potentially inappropriate medications in people with dementia in Vietnam and its associated factors
Use of potentially inappropriate medications in people with dementia in Vietnam and its associated factors 33 rd International Conference of Alzheimer s Disease International 26 29 July 2018, Chicago,
More informationAkinbolade O, Husband A, Forrest S, Todd A. Deprescribing in advanced illness. Progress in Palliative Care 2016, 24(5),
Akinbolade O, Husband A, Forrest S, Todd A. Deprescribing in advanced illness. Progress in Palliative Care 2016, 24(5), 268-271 Copyright: This is an Accepted Manuscript of an article published by Taylor
More informationInterdisciplinary detection of potential drug related problems in older people
Interdisciplinary detection of potential drug related problems in older people Prof. dr. Mirko Petrovic Department of Internal Medicine, Ghent University Department of Geriatrics, Ghent University Hospital,
More informationSiGMA/ MMHSCT GUIDELINES FOR ANTIPSYCHOTIC DRUG TREATMENT OF SCHIZOPHRENIA. [compatible with NICE guidance]
SiGMA/ MMHSCT GUIDELINES FOR ANTIPSYCHOTIC DRUG TREATMENT OF SCHIZOPHRENIA [compatible with NICE guidance] Medicines Management Committee August 2002 For review August 2003 Rationale The SiGMA algorithm
More informationMedication Use in Older Adults
Medication Use in Older Adults F. Michael Gloth, III, MD, AGSF, FACP, CMD Clinical Professor Department of Geriatrics, Florida State University College of Medicine Associate Professor of Medicine Division
More information